Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
C09DA Angiotensin II receptor blockers (ARBs) and diuretics
C09DA07 Telmisartan and diuretics
D09219 Telmisartan and hydrochlorothiazide (JP18) <JP/US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Cardiovascular Agents, Combinations
Hydrochlorothiazide/ Telmisartan
D09219 Telmisartan and hydrochlorothiazide (JP18)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
214 Antihypertensives
2149 Others
D09219 Telmisartan and hydrochlorothiazide (JP18)
Drug groups [BR:br08330]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
D09219 Telmisartan and hydrochlorothiazide
DG03231 Antihypertensive
D09219 Telmisartan and hydrochlorothiazide
Metabolizing enzyme substrate
DG02924 UGT substrate
D09219 Telmisartan and hydrochlorothiazide
Drug classes [BR:br08332]
Cardiovascular agent
DG03231 Antihypertensive
D09219 Telmisartan and hydrochlorothiazide
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D09219 Telmisartan and hydrochlorothiazide tablets
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09219
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09219